Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Clinical trial NCT01597193 · COMPLETED
Trial details
- NCT number
- NCT01597193
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-30
- Primary completion
- 2015-12-15
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.